Recently DePuy Orthopaedics, a division of Johnson & Johnson, announced that is it recalling the ASR XL Acetabular System, which is used for total hip replacements, and the ASR Hip Resurfacing System, which is used in a newer kind of bone-conserving procedure. The FDA had approved both hip replacement systems, and the total hip replacement system had been used in patients in the United States. Even though the hip resurfacing system was not approved for use in the United States, some patients in the U.S. received the implant through a clinical trial. A combined total of about 93,000 of the DePuy devices have been implanted worldwide.
New data revealed that about 1 in 8, or about 12 percent, of those who received the implants needed corrective procedures or revision surgeries within five years. This prompted DePuy to implement a massive recall of its products.
According to expert orthopedic surgeons, the failure rate of DePuy's hip replacement systems is about twice the industry average. The cause of DePuy's devices was due to a design failure that was not picked up by DePuy prior to exposing thousands of people to the defective product. Most people who replace a hip or knee can expect their new implants to last for the rest of their lives if the implant is manufactured correctly and up to industry standards. If revision surgery is necessary, the revisions are more complicated and costly than the primary joint replacements because surgeons have less bone and more scar tissue to work with. Therefore, having a defective devise could get very costly not to mention the pain and agony associated with undergoing a second surgery.
If you believe to have a DePuy devise implanted in your hip, you should get a medical examination as soon as possible. The statute of limitations could be running on your case.